Details for Patent: 3,886,134
✉ Email this page to a colleague
Summary for Patent: 3,886,134
Title: | Analogues of angiotensin II |
Abstract: | Novel hepta- and octapeptides of the formula: ##SPC1## Wherein R is hydrogen, succinyl, L-aspartyl, L-sarcosyl, L-seryl, succinamyl, or D- or L-asparaginyl and R.sub.1 is an L-alanine, L- or D-leucine, glycine or L-isoleucine residue upon intravenous infusion to animals inhibit blood pressure response to angiotensin amide. |
Inventor(s): | Sipos; Frank (Norwich, NY), Pals; Donald T. (Oxford, NY), Denning; George S. (Norwich, NY) |
Assignee: | Morton-Norwich Products, Inc. (Norwich, NY) |
Application Number: | 05/043,595 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 3,886,134
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 3,886,134
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 333986 | ⤷ Sign Up | |||
Austria | A483471 | ⤷ Sign Up | |||
Belgium | 767784 | ⤷ Sign Up | |||
Canada | 940120 | ⤷ Sign Up | |||
Switzerland | 555807 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |